pharmaceutical investing Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical investing Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome
Blue Lagoon Secures $2 Million Line of Credit from Nicola Mining Enhancing Financial Flexibility Ahead of Production
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements
